Diabetes and cardiometabolic companies face safety, efficacy, and regulatory exposure that most brands never encounter. We create the plan, message library, and decision rules before a crisis strikes – so your response safeguards patients and credibility rather than making the problem worse.
The Challenge
A question about safety or efficacy is not a typical PR problem
When a patient reports an adverse event, a study gets questioned, or a device reading is disputed, a generic PR playbook makes it worse. Downplaying a real safety concern in a diabetes or cardiometabolic category is both a trust failure and a regulatory one. The response has to be accurate, medically defensible, and fast at the same time, which is a standard most communications teams have never had to meet.
Regulators, clinicians, and patients interpret the same statement differently
A reassurance that calms patients can read as an unsupported claim to the FDA and as spin to a clinician deciding whether to keep recommending you. One message cannot serve all three, yet issuing three contradictory ones destroys credibility faster than silence. Coordinating a response that holds up across regulatory, clinical, and patient audiences is the core difficulty in this category.
Speed and legal review work in opposite directions
The window to shape the narrative closes in hours, but legal and clinical review can take days, and skipping that review creates exposure that outlasts the news cycle. Teams without a pre-built framework freeze in that gap, and silence gets read as guilt. The fix is deciding in advance what can be said, by whom, and how fast, so review accelerates the response instead of blocking it.
Without a plan, a small incident can become a category event
A single social post about a side effect, a short seller's report, or a payer pulling coverage can escalate when no one owns the response. Without clear roles, holding statements, and escalation triggers, the first 24 hours are spent arguing internally while the story writes itself. Most reputational damage in this space comes from the delay, not the incident.
How We Help
We begin by mapping your real exposure – the safety, efficacy, regulatory, coverage, and data-privacy scenarios unique to a diabetes or cardiometabolic company – and ranking each by likelihood and severity. This transforms the abstract fear of "a crisis" into a defined set of situations you can prepare to handle. It ties directly to the [growth strategy](/services/strategy/) work, since reputation risk is also growth risk.
For the highest-priority scenarios, we create a message architecture that works across audiences. We prepare holding statements, clinician-facing explanations, patient reassurance, and regulator-ready language that communicate the same true story at varying levels of depth. A single accurate spine is what prevents the contradictory-messaging failure that undermines most responses.
Before anything happens, we establish the decision rules and roles: who verifies facts with the clinical team, who leads legal review, who approves external statements, and what prompts escalation. Agreeing on this in advance eliminates the paralysis of the first 24 hours, because the team follows a plan rather than debating one.
We build the response into your [marketing](/services/marketing/) and owned channels, allowing you to reach patients and clinicians directly rather than only through the press. Owning your channels means you do not have to rely on a reporter's framing to set the record straight.
Following any event – or drill – we use our [measurement](/services/measurement/) practice to assess what the response did to sentiment, coverage, clinician confidence, and enrollment, making the plan more precise each time. Crisis readiness is an ongoing capability to build and maintain, not a document left sitting in a drawer.
We do not deliver a binder and walk away. We create the plan, rehearse it, and remain embedded so that when something goes wrong, you already know exactly how to respond.
What we deliver
- A ranked exposure map of the safety, regulatory, and coverage scenarios specific to your category
- A message architecture with statements for patients, clinicians, and regulators built from one accurate spine
- Decision rules, roles, and escalation triggers agreed before any incident
- Pre-drafted holding statements and channel plans for the highest-risk scenarios
- A tabletop drill to test the plan against a realistic scenario
- Post-event measurement tying response to sentiment, coverage, and clinician confidence
In diabetes and cardiometabolic health, a crisis itself rarely destroys the company – the improvised response does, because language that reassures patients may also look like an unsupported claim to regulators and spin to clinicians, and only a pre-built architecture grounded in one accurate spine can withstand all three interpretations.
Our Methodology
Our 90-day sprint turns crisis readiness into a working capability, not a static document. Days 1-30 center on exposure mapping: together with your clinical, regulatory, and legal leads, we identify the scenarios your particular product and category genuinely face, then rank them by likelihood and severity so preparation addresses real risks rather than generic PR concerns.
Days 31-60 are devoted to building the response machinery. We develop the message architecture for the leading scenarios, establish roles and decision rules, and pre-draft holding statements and channel plans. Legal and clinical teams review everything in advance, meaning the review that typically delays a live response is already complete for likely situations.
Days 61-90 focus on testing and transfer. We conduct a tabletop drill based on a realistic scenario to uncover gaps, adjust the plan according to how the team performs in practice, and document the playbook and triggers so your team can use it without us present. Because readiness declines as teams and products change, the sprint puts both a plan and a maintenance cadence in place instead of producing a one-off deliverable.
How We Work
During the first 30 days, we collaborate closely with your regulatory, clinical, and legal leads, since communicators alone cannot create a credible crisis plan for this category. Expect working sessions focused on mapping exposure scenarios and agreeing on what may and may not be said in each case.
Days 30-60 move into building the response machinery. Instead of creating a generic PR plan, we develop scenario-specific message architecture, pre-drafted statements, defined roles, and clear escalation triggers, all reviewed in advance so a live response does not stall while awaiting first-time legal approval.
Days 60-90 focus on rehearsal and handoff. We conduct a tabletop drill, refine the plan based on how the team responds under pressure, and document the playbook so your team can own it. Since readiness must endure product changes and team turnover, many engagements continue with a lighter retainer to maintain the plan and conduct periodic drills.
The team brings together a communications strategist responsible for the message architecture and a senior operator who leads the drills and decision-rule design. They work with your internal legal, clinical, and regulatory owners rather than taking their place.
- Faster, more accurate first-24-hours response
- Consistent messaging across patient, clinician, and regulator audiences
- Reduced regulatory and legal exposure from improvised statements
- Direct owned-channel reach to correct the record
- A rehearsed team that executes instead of debating
If your diabetes & cardiometabolic health company needs crisis communications leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does crisis communications cost for a diabetes or cardiometabolic company?
A comprehensive readiness program typically costs $20K-$45K for the first 90-day engagement, based on the number of scenarios requiring scenario-specific message architecture and the level of clinical and legal coordination involved. Ongoing retainers for keeping the plan updated and conducting drills are smaller. Compared with the expense of an improvised response that prompts regulatory scrutiny or costs you payer coverage, readiness is inexpensive insurance.
How does crisis comms for a health company differ from that of a normal brand?
Unlike a normal brand crisis, a safety or efficacy question creates regulatory and clinical exposure, so the standard impulse to offer quick reassurance may lead to genuine legal liability. Regulators, clinicians, and patients interpret the same statement differently, meaning a single message seldom works for everyone. This is why we create a message architecture around one accurate spine instead of relying on a generic press response.
How quickly can you help us respond if something is already happening?
When we have developed the plan beforehand, an initial holding statement can be issued within the hour because roles, decision rules, and pre-reviewed language are already established. If you approach us mid-crisis with no plan, we can still stabilize your response, but the first day goes toward creating what should already have been in place. The purpose of readiness work is to shorten that response window before it is needed.
How do you respond quickly without creating regulatory exposure?
We have your legal and clinical teams pre-review the message architecture for likely scenarios, meaning the review that usually delays a live statement is already complete. Decision rules specify exactly who verifies facts and who approves wording, preventing anyone from improvising a claim while under pressure. The objective is a response that is fast as well as defensible, without sacrificing either one.
How do you determine whether the crisis plan actually worked?
Following an actual event or drill, we monitor changes in sentiment, coverage tone, clinician confidence, and any effect on enrollment or coverage, then measure the results against the pre-incident baseline. We also assess response time and internal execution relative to the plan to identify where the team paused or hesitated. Every measurement cycle improves the playbook, making the next response faster and cleaner.
What does the process of getting started with crisis readiness involve?
We start by identifying the safety, regulatory, and coverage scenarios your particular product genuinely faces and ranking them by risk in collaboration with your clinical and legal leads. This creates a prioritized exposure map before we draft even one statement. If your diabetes or cardiometabolic company lacks a rehearsed plan for a safety or regulatory event, we should speak before one becomes necessary.
